Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: A microdialysis study

Neuroscience Letters

Volumn 552, Issue , 2013, Pages 5-9

  Alfaro Rodriguez, Alfonso ^a   Alonso Spilsbury, María ^b   Arch Tirado, Emilio ^a   Gonzalez Pina, Rigoberto ^a   Arias Montaño, José Antonio ^c   Bueno Nava, Antonio ^a,d  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

D1 receptor; Dopamine; Dopamine release; H3 receptor; Histamine; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMMEPIP; THIOPERAMIDE; UNCLASSIFIED DRUG; 4 (1H IMIDAZOL 4 YLMETHYL)PIPERIDINE; 4-(1H-IMIDAZOL-4-YLMETHYL)PIPERIDINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; D(1) RECEPTOR; D(1)R; D(2)R; DA; DOPAMINE D(1) RECEPTOR; DOPAMINE D(2) RECEPTOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; H(3) RECEPTOR; H(3)R; HISTAMINE H(3) RECEPTOR; MEDIUM SPINY NEURONS; METABOLISM; MICROINJECTION; MSNS; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

D(1) RECEPTOR; D(1)R; D(2)R; DA; DOPAMINE; DOPAMINE D(1) RECEPTOR; DOPAMINE D(2) RECEPTOR; DOPAMINE RELEASE; H(3) RECEPTOR; H(3)R; HISTAMINE; HISTAMINE H(3) RECEPTOR; MEDIUM SPINY NEURONS; MSNS; STRIATUM;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DRUG INTERACTIONS; HISTAMINE AGONISTS; HISTAMINE H3 ANTAGONISTS; IMIDAZOLES; MALE; MICRODIALYSIS; MICROINJECTIONS; PIPERIDINES; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, HISTAMINE H3; SYNAPTIC TRANSMISSION;

EID: 84884273474     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.07.026     Document Type: Article

References (42)

1. Abraini J.H., Fechtali T., Rostain J.C. Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study. Brain Research 1994, 642:199-205.
2. 3H]-gamma-aminobutryic acid from rat striatal slices. British Journal of Pharmacology 2001, 133:165-171.
3. 3 receptor. Trends in Pharmacological Sciences 2007, 28:350-357.
4. 5 dopamine receptors in primate brain. Journal of Neuroscience 1995, 15:7821-7836.
5. Bolam J.P., Hanley J.J., Booth P.A.C., Bevan M.D. Synaptic organisation of the basal ganglia. Journal of Anatomy 2000, 196:527-542.
6. 1 dopamine receptor results in an increase of metabolized dopamine in the rat striatum. Neurochemical Research 2012, 37:1783-1789.
7. Bueno-Nava A., González-Piña R., Ávila-Luna A., Alfaro-Rodríguez A. Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat. Revista de Neurologia 2011, 52:371-377.
8. 2 dopamine receptor cDNA. Nature 1988, 336:783-787.
9. 3 receptors. British Journal of Pharmacology 2009, 157:64-75.
10. Festing M.F. Reduction of animal use: experimental design and quality of experiments. Laboratory Animals 1994, 28:212-221.
11. 3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulate. Neuroscience 1997, 80:241-249.
12. Gerfen C.R., Wilson C.J. The basal ganglia. Handbook of Chemical Neuroanatomy 1996, vol. 12:369-466. Elsevier, Amsterdam. A. Björklund, T. Hökfelt, L. Swanson (Eds.).
13. 3 receptor in the basal ganglia: functional modulation of dopamine and glutamate neurotransmission. Basal Ganglia 2013, 3:109-121.
14. Grillner P., Berretta N., Bernardi G., Svensson T.H., Mercuri N.B. Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons. Neuroscience 2000, 96:299-307.
15. Imperato A., Mulas A., Di Chiara G. The D-1 antagonist SCH23390 stumulates while the D-1 agonist SKF38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. European Journal of Pharmacology 1987, 142:177-181.
16. Imperato A., Di Chiara G. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. European Journal of Pharmacology 1988, 156:385-393.
17. Kandel E.R., Schwartz J.H., Jessell T.M., Siegelbaum S.A., Hudspeth A.J. Principles of Neural Science 2013, McGraw-Hill, New York. fifth ed.
18. Kayadjanian N., Gioanni H., Ménetrey A., Besson M.J. Muscarinic receptor stimulation increases the spontaneous [3H]GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals. Neuroscience 1994, 63:989-1002.
19. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554.
20. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. Journal of Comparative Neurology 1995, 355:418-426.
21. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiological Reviews 1998, 78:189-225.
22. 3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. Journal of Biological Chemistry 2011, 286:5846-5854.
23. Olfert E.D., Cross B.M., Mc William A.A. Guide for the care and use of experimental animals. Canadian Council on Animal Care 1993, 1:211.
24. Paxinos G., Watson C.C. The Rat Brain in Stereotaxic Coordinates 2007, Academic, New York. sixth ed.
25. 3 receptor and its gene transcripts in rat brain. Neuroscience 2002, 114:173-193.
26. 3 histamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 1999, 360:558-564.
27. 2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). Journal of Neurochemistry 2001, 77:1248-1255.
28. 2 receptors in rat brain. Neuroreport 1994, 31:621-624.
29. Saklayen S.S., Mabrouk O.S., Pehek E.A. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. Journal of Pharmacology and Experimental Therapeutics 2004, 311:342-348.
30. 1 receptor-induced cAMP accumulation in rat striatal slices. Neuroscience Letters 2004, 364:179-184.
31. 3 receptors. Journal of Neural Transmission: General Section 1993, 93:1-10.
32. 3 receptor. Journal of Neural Transmission. Supplementa 2003, 64:1-16.
33. Smits R.P.J.M., Mulder A.H. Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochemistry International 1991, 18:215-220.
34. Smolders I., De Klippel N., Sarre S., Ebinger G., Michotte Y. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. European Journal of Pharmacology 1995, 284:83-91.
35. 1. Nature 1991, 350:614-619.
36. Surmeier D.J., Ding J., Day M., Wang Z., Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends in Neurosciences 2007, 30:228-235.
37. Surmeier D.J., Song W.-J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience 1996, 16:6579-6591.
38. 3 receptors. Journal of Pharmacology and Experimental Therapeutics 2003, 307:213-218.
39. 3 receptors inhibit serotonin release in substantia nigra pars reticulata. Journal of Neuroscience 2004, 24:8704-8710.
40. Valjent E., Bertran-Gonzalez J., Hervé D., Fisone G., Girault J.A. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends in Neurosciences 2009, 32:538-547.
41. 4 receptor with high affinity for the antipsychotic clozapine. Nature 1991, 350:610-614.
42. Zackheim J.A., Abercrombie E.D. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Brain Research Bulletin 2001, 54:603-607.